{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T19:29:21Z","timestamp":1783452561623,"version":"3.55.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82300011"],"award-info":[{"award-number":["82300011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82173182"],"award-info":[{"award-number":["82173182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Noncommunicable Chronic Diseases\u2013National Science and Technology Major Project","award":["2024ZD0529501 \/ 2024ZD0529500"],"award-info":[{"award-number":["2024ZD0529501 \/ 2024ZD0529500"]}]},{"name":"Science and Technology Program of Sichuan Province","award":["2023NSFSC1939"],"award-info":[{"award-number":["2023NSFSC1939"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-026-03609-2","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T09:04:35Z","timestamp":1772701475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A lung microbial signature for postoperative recurrence in stage I\u2013II non-small cell lung cancer"],"prefix":"10.1186","volume":"27","author":[{"given":"Chunyan","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guonian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchuang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"3609_CR1","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.athoracsur.2014.05.070","volume":"98","author":"F Lou","year":"2014","unstructured":"Lou F, Sima CS, Rusch VW, Jones DR, Huang J. Differences in patterns of recurrence in early-stage versus locally advanced non-small cell lung cancer. Ann Thorac Surg. 2014;98:1755\u201361.","journal-title":"Ann Thorac Surg"},{"key":"3609_CR2","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.athoracsur.2023.06.004","volume":"116","author":"AL Potter","year":"2023","unstructured":"Potter AL, Costantino CL, Suliman RA, Haridas CS, Senthil P, Kumar A, Mayne NR, Panda N, Martin LW, Yang C-FJ. Recurrence After Complete Resection for Non-Small Cell Lung Cancer in the National Lung Screening Trial. Ann Thorac Surg. 2023;116:684\u201392.","journal-title":"Ann Thorac Surg"},{"key":"3609_CR3","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","volume":"398","author":"E Felip","year":"2021","unstructured":"Felip E, Altorki N, Zhou C, Cs\u0151szi T, Vynnychenko I, Goloborodko O, Luft A, Akopov A, Martinez-Marti A, Kenmotsu H, et al. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB\u2013IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial. Lancet. 2021;398:1344\u201357.","journal-title":"Lancet"},{"key":"3609_CR4","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","volume":"26","author":"J-P Pignon","year":"2008","unstructured":"Pignon J-P, Tribodet H, Scagliotti GV, Douillard J-Y, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell R, Seymour L, et al. Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group. J Clin Oncol. 2008;26:3552\u20139.","journal-title":"J Clin Oncol"},{"key":"3609_CR5","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1200\/JCO.22.02186","volume":"41","author":"RS Herbst","year":"2023","unstructured":"Herbst RS, Wu Y-L, John T, Grohe C, Majem M, Wang J, Kato T, Goldman JW, Laktionov K, Kim S-W, et al. Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non\u2013Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial. J Clin Oncol. 2023;41:1830\u201340.","journal-title":"J Clin Oncol"},{"key":"3609_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1056\/NEJMoa2304594","volume":"389","author":"M Tsuboi","year":"2023","unstructured":"Tsuboi M, Herbst Roy S, John T, Kato T, Majem M, Groh\u00e9 C, Wang J, Goldman Jonathan W, Lu S, Su W-C, et al. Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC. N Engl J Med. 2023;389:137\u201347.","journal-title":"N Engl J Med"},{"key":"3609_CR7","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1056\/NEJMoa2310532","volume":"390","author":"Y-L Wu","year":"2024","unstructured":"Wu Y-L, Dziadziuszko R, Ahn Jin S, Barlesi F, Nishio M, Lee Dae H, Lee J-S, Zhong W, Horinouchi H, Mao W, et al. Alectinib in Resected ALK-Positive Non\u2013Small-Cell Lung Cancer. N Engl J Med. 2024;390:1265\u201376.","journal-title":"N Engl J Med"},{"key":"3609_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.annonc.2023.07.001","volume":"34","author":"E Felip","year":"2023","unstructured":"Felip E, Altorki N, Zhou C, Valli\u00e8res E, Mart\u00ednez-Mart\u00ed A, Rittmeyer A, Chella A, Reck M, Goloborodko O, Huang M, et al. Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial. Ann Oncol. 2023;34:907\u201319.","journal-title":"Ann Oncol"},{"key":"3609_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.trecan.2024.04.004","volume":"10","author":"C Abbosh","year":"2024","unstructured":"Abbosh C, Hodgson D, Doherty GJ, Gale D, Black JRM, Horn L, Reis-Filho JS, Swanton C. Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer. Trends Cancer. 2024;10:643\u201354.","journal-title":"Trends Cancer"},{"key":"3609_CR10","doi-asserted-by":"crossref","unstructured":"Jiang Y, Lin Y, Fu W, He Q, Liang H, Zhong R, et al. The impact of adjuvant EGFR-TKIs and 14-gene molecular assay on stage I non\u2013small cell lung cancer with sensitive EGFR mutations. EClinical Medicine. 2023;64:102205.","DOI":"10.1016\/j.eclinm.2023.102205"},{"key":"3609_CR11","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0140-6736(11)61941-7","volume":"379","author":"JR Kratz","year":"2012","unstructured":"Kratz JR, He J, Van Den Eeden SK, Zhu Z-H, Gao W, Pham PT, Mulvihill MS, Ziaei F, Zhang H, Su B, et al. A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet. 2012;379:823\u201332.","journal-title":"Lancet"},{"key":"3609_CR12","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/JTO.0000000000000560","volume":"10","author":"AI Robles","year":"2015","unstructured":"Robles AI, Arai E, Math\u00e9 EA, Okayama H, Schetter AJ, Brown D, Petersen D, Bowman ED, Noro R, Welsh JA, et al. An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers. J Thorac Oncol. 2015;10:1037\u201348.","journal-title":"J Thorac Oncol"},{"key":"3609_CR13","doi-asserted-by":"crossref","unstructured":"Wang C, Li J, Chen J, Wang Z, Zhu G, Song L, et al. Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer. Nat Commun. 2025;16:1477.","DOI":"10.1038\/s41467-024-55068-2"},{"key":"3609_CR14","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.ccell.2021.08.006","volume":"39","author":"N Cullin","year":"2021","unstructured":"Cullin N, Azevedo Antunes C, Straussman R, Stein-Thoeringer CK, Elinav E. Microbiome and cancer. Cancer Cell. 2021;39:1317\u201341.","journal-title":"Cancer Cell"},{"key":"3609_CR15","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, Rotter-Maskowitz A, Weiser R, Mallel G, Gigi E, et al. The human tumor microbiome is composed of tumor type\u2013specific intracellular bacteria. Science. 2020;368:973\u201380.","journal-title":"Science"},{"key":"3609_CR16","unstructured":"Sepich-Poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R. The microbiome and human cancer. Science. 2021;371:eabc4552."},{"key":"3609_CR17","doi-asserted-by":"publisher","first-page":"e8578","DOI":"10.1371\/journal.pone.0008578","volume":"5","author":"M Hilty","year":"2010","unstructured":"Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, Davies J, Ervine A, Poulter L, Pachter L, et al. Disordered microbial communities in asthmatic airways. PLoS ONE. 2010;5:e8578.","journal-title":"PLoS ONE"},{"key":"3609_CR18","doi-asserted-by":"crossref","unstructured":"Dickson RP, Huffnagle GB. The lung microbiome: new principles for respiratory bacteriology in health and disease. PLoS Pathog. 2015;11:e1004923.","DOI":"10.1371\/journal.ppat.1004923"},{"key":"3609_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrmicro.2017.14","volume":"15","author":"WH Man","year":"2017","unstructured":"Man WH, de Steenhuijsen Piters WAA, Bogaert D. The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol. 2017;15:259\u201370.","journal-title":"Nat Rev Microbiol"},{"key":"3609_CR20","first-page":"2350","volume":"12","author":"OH Kim","year":"2022","unstructured":"Kim OH, Choi BY, Kim DK, Kim NH, Rho JK, Sul WJ, Lee SW. The microbiome of lung cancer tissue and its association with pathological and clinical parameters. Am J Cancer Res. 2022;12:2350\u201362.","journal-title":"Am J Cancer Res"},{"key":"3609_CR21","first-page":"2047","volume":"9","author":"D Huang","year":"2019","unstructured":"Huang D, Su X, Yuan M, Zhang S, He J, Deng Q, Qiu W, Dong H, Cai S. The characterization of lung microbiome in lung cancer patients with different clinicopathology. Am J Cancer Res. 2019;9:2047\u201363.","journal-title":"Am J Cancer Res"},{"key":"3609_CR22","doi-asserted-by":"crossref","unstructured":"Yu G, Gail MH, Consonni D, Carugno M, Humphrys M, Pesatori AC, et al. Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features. Genome Biol. 2016;17:163.","DOI":"10.1186\/s13059-016-1021-1"},{"key":"3609_CR23","doi-asserted-by":"crossref","unstructured":"Greathouse KL, White JR, Vargas AJ, Bliskovsky VV, Beck JA, von Muhlinen N, et al. Interaction between the microbiome and TP53 in human lung cancer. Genome Biol. 2018;19:123.","DOI":"10.1186\/s13059-018-1501-6"},{"key":"3609_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2022.07.006","volume":"86","author":"T Goto","year":"2022","unstructured":"Goto T. Microbiota and lung cancer. Sem Cancer Biol. 2022;86:1\u201310.","journal-title":"Sem Cancer Biol"},{"key":"3609_CR25","doi-asserted-by":"crossref","unstructured":"Li B, Wang D, Zhang C, Wang Y, Huang Z, Yang L, et al. Role of respiratory system microbiota in development of lung cancer and clinical application. iMeta. 2024;3:e232.","DOI":"10.1002\/imt2.232"},{"key":"3609_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1158\/2159-8290.CD-20-0263","volume":"11","author":"J-CJ Tsay","year":"2021","unstructured":"Tsay J-CJ, Wu BG, Sulaiman I, Gershner K, Schluger R, Li Y, Yie T-A, Meyn P, Olsen E, Perez L, et al. Lower Airway Dysbiosis Affects Lung Cancer Progression. Cancer Discov. 2021;11:293\u2013307.","journal-title":"Cancer Discov"},{"key":"3609_CR27","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1164\/rccm.201710-2118OC","volume":"198","author":"J-CJ Tsay","year":"2018","unstructured":"Tsay J-CJ, Wu BG, Badri MH, Clemente JC, Shen N, Meyn P, Li Y, Yie T-A, Lhakhang T, Olsen E, et al. Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer. Am J Respir Crit Care Med. 2018;198:1188\u201398.","journal-title":"Am J Respir Crit Care Med"},{"key":"3609_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.lungcan.2016.10.016","volume":"102","author":"SH Lee","year":"2016","unstructured":"Lee SH, Sung JY, Yong D, Chun J, Kim SY, Song JH, Chung KS, Kim EY, Jung JY, Kang YA, et al. Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions. Lung Cancer. 2016;102:89\u201395.","journal-title":"Lung Cancer"},{"key":"3609_CR29","doi-asserted-by":"crossref","unstructured":"Peters BA, Pass HI, Burk RD, Xue X, Goparaju C, Sollecito CC, et al. The lung microbiome, peripheral gene expression, and recurrence-free survival after resection of stage II non-small cell lung cancer. Genome Med. 2022;14:121.","DOI":"10.1186\/s13073-022-01126-7"},{"key":"3609_CR30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jtcvs.2020.01.104","volume":"161","author":"SK Patnaik","year":"2021","unstructured":"Patnaik SK, Cortes EG, Kannisto ED, Punnanitinont A, Dhillon SS, Liu S, et al. Lower airway bacterial microbiome may influence recurrence after resection of early-stage non\u2013small cell lung cancer. J Thorac Cardiovasc Surg. 2021;161:419\u201329.e16.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3609_CR31","doi-asserted-by":"crossref","unstructured":"Chen H, Ma Y, Xu J, Wang W, Lu H, Quan C, et al. Circulating microbiome DNA as biomarkers for early diagnosis and recurrence of lung cancer. Cell Rep Med. 2024;5:101499.","DOI":"10.1016\/j.xcrm.2024.101499"},{"key":"3609_CR32","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.1127059","volume":"313","author":"J-P Nougayr\u00e8de","year":"2006","unstructured":"Nougayr\u00e8de J-P, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, Buchrieser C, Hacker J, Dobrindt U, Oswald E. Escherichia coli Induces DNA Double-Strand Breaks in Eukaryotic Cells. Science. 2006;313:848\u201351.","journal-title":"Science"},{"key":"3609_CR33","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.immuni.2013.12.007","volume":"40","author":"N Singh","year":"2014","unstructured":"Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, Thangaraju M, Prasad Puttur D, Manicassamy S, Munn David H, et al. Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis. Immunity. 2014;40:128\u201339.","journal-title":"Immunity"},{"key":"3609_CR34","doi-asserted-by":"crossref","unstructured":"Ma Y, Chen H, Li H, Zheng M, Zuo X, Wang W, et al. Intratumor microbiome-derived butyrate promotes lung cancer metastasis. Cell Rep Med. 2024;5:101488.","DOI":"10.1016\/j.xcrm.2024.101488"},{"key":"3609_CR35","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.cmet.2024.12.013","volume":"37","author":"X Zhu","year":"2025","unstructured":"Zhu X, Hu M, Huang X, Li L, Lin X, Shao X, et al. Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses. Cell Metabol. 2025;37:806\u201323.e6.","journal-title":"Cell Metabol"},{"key":"3609_CR36","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jtho.2024.02.011","volume":"19","author":"R Rami-Porta","year":"2024","unstructured":"Rami-Porta R, Nishimura KK, Giroux DJ, Detterbeck F, Cardillo G, Edwards JG, Fong KM, Giuliani M, Huang J, Kernstine KH, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2024;19:1007\u201327.","journal-title":"J Thorac Oncol"},{"key":"3609_CR37","doi-asserted-by":"crossref","unstructured":"Sun Z, Huang S, Zhu P, Tzehau L, Zhao H, Lv J, et al. Species-resolved sequencing of low-biomass or degraded microbiomes using 2bRAD-M. Genome Biol. 2022;23:36.","DOI":"10.1186\/s13059-021-02576-9"},{"key":"3609_CR38","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nmeth.2023","volume":"9","author":"S Wang","year":"2012","unstructured":"Wang S, Meyer E, McKay JK, Matz MV. 2b-RAD: a simple and flexible method for genome-wide genotyping. Nat Methods. 2012;9:808\u201310.","journal-title":"Nat Methods"},{"key":"3609_CR39","unstructured":"Oksanen J, Simpson GL, Blanchet FG, Kindt R, Legendre P, Minchin PR, O\u2019Hara RB, Solymos P, Stevens MHH, Szoecs E et al. vegan: Community Ecology Package. 2025."},{"key":"3609_CR40","doi-asserted-by":"crossref","unstructured":"Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60.","DOI":"10.1186\/gb-2011-12-6-r60"},{"key":"3609_CR41","doi-asserted-by":"publisher","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","volume":"50","author":"DS Wishart","year":"2022","unstructured":"Wishart DS, Guo A, Oler E, Wang F, Anjum A, Peters H, Dizon R, Sayeeda Z, Tian S, Lee Brian L, et al. HMDB 5.0: the Human Metabolome Database for 2022. Nucleic Acids Res. 2022;50:D622\u201331.","journal-title":"Nucleic Acids Res"},{"key":"3609_CR42","doi-asserted-by":"publisher","first-page":"D1677","DOI":"10.1093\/nar\/gkad896","volume":"52","author":"MJ Conroy","year":"2024","unstructured":"Conroy MJ, Andrews RM, Andrews S, Cockayne L, Dennis Edward A, Fahy E, Gaud C, Griffiths William J, Jukes G, Kolchin M, et al. LIPID MAPS: update to databases and tools for the lipidomics community. Nucleic Acids Res. 2024;52:D1677\u201382.","journal-title":"Nucleic Acids Res"},{"key":"3609_CR43","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/01.ftd.0000179845.53213.39","volume":"27","author":"CA Smith","year":"2005","unstructured":"Smith CA, Maille GO, Want EJ, Qin C, Trauger SA, Brandon TR, Custodio DE, Abagyan R, Siuzdak G. METLIN: A Metabolite Mass Spectral Database. Ther Drug Monit. 2005;27:747\u201351.","journal-title":"Ther Drug Monit"},{"key":"3609_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28:27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"3609_CR45","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/metabo10050186","volume":"10","author":"Z Pang","year":"2020","unstructured":"Pang Z, Chong J, Li S, Xia J. MetaboAnalystR 3.0: Toward an Optimized Workflow for Global Metabolomics. Metabolites. 2020;10:186.","journal-title":"Metabolites"},{"key":"3609_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random Forests. Mach Learn. 2001;45:5\u201332.","journal-title":"Mach Learn"},{"key":"3609_CR47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"SM Lundberg","year":"2020","unstructured":"Lundberg SM, Erion G, Chen H, DeGrave A, Prutkin JM, Nair B, Katz R, Himmelfarb J, Bansal N, Lee S-I. From local explanations to global understanding with explainable AI for trees. Nat Mach Intell. 2020;2:56\u201367.","journal-title":"Nat Mach Intell"},{"key":"3609_CR48","unstructured":"Cs\u00e1rdi G, Nepusz T, Traag V, Horv\u00e1t S, Zanini F, Noom D. M\u00fcller K: igraph: Network Analysis and Visualization in R. 2025."},{"key":"3609_CR49","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s43588-022-00247-8","volume":"2","author":"L Xiao","year":"2022","unstructured":"Xiao L, Zhang F, Zhao F. Large-scale microbiome data integration enables robust biomarker identification. Nat Comput Sci. 2022;2:307\u201316.","journal-title":"Nat Comput Sci"},{"key":"3609_CR50","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.1093\/bioinformatics\/btac672","volume":"38","author":"P-A Chaumeil","year":"2022","unstructured":"Chaumeil P-A, Mussig AJ, Hugenholtz P, Parks DH. GTDB-Tk v2: memory friendly classification with the genome taxonomy database. Bioinformatics. 2022;38:5315\u20136.","journal-title":"Bioinformatics"},{"key":"3609_CR51","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/bioinformatics\/bty633","volume":"35","author":"E Paradis","year":"2019","unstructured":"Paradis E, Schliep K. ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R. Bioinformatics. 2019;35:526\u20138.","journal-title":"Bioinformatics"},{"key":"3609_CR52","doi-asserted-by":"crossref","unstructured":"Xu S, Li L, Luo X, Chen M, Tang W, Zhan L, et al. Ggtree: a serialized data object for visualization of a phylogenetic tree and annotation data. iMeta. 2022;1:e56.","DOI":"10.1002\/imt2.56"},{"key":"3609_CR53","unstructured":"Therneau TM. A Package for Survival Analysis in R. 2024."},{"key":"3609_CR54","doi-asserted-by":"crossref","unstructured":"Zhang Y, Chen X-X, Chen R, Li L, Ju Q, Qiu D, et al. Lower respiratory tract microbiome dysbiosis impairs clinical responses to immune checkpoint blockade in advanced non-small-cell lung cancer. Clin Translational Med. 2025;15:e70170.","DOI":"10.1002\/ctm2.70170"},{"key":"3609_CR55","doi-asserted-by":"crossref","unstructured":"Zhang J, Wu Y, Liu J, Yang Y, Li H, Wu X, et al. Differential oral microbial input determines two microbiota pneumo-types associated with health status. Adv Sci. 2022;9:2203115.","DOI":"10.1002\/advs.202203115"},{"key":"3609_CR56","doi-asserted-by":"crossref","unstructured":"Guo J, Han J, Li F, Ma Q, He J, You F, et al. 16S rRNA sequencing reveals relationships among enrichment of oral microbiota in the lower respiratory tract and pulmonary nodules malignant progression. Microbiol Spectr. 2025;13:e01284\u201324.","DOI":"10.1128\/spectrum.01284-24"},{"key":"3609_CR57","doi-asserted-by":"crossref","unstructured":"Price LB, Hungate BA, Koch BJ, Davis GS, Liu CM. Colonizing opportunistic pathogens (COPs): the beasts in all of us. PLoS Pathog. 2017;13:e1006369.","DOI":"10.1371\/journal.ppat.1006369"},{"key":"3609_CR58","doi-asserted-by":"crossref","unstructured":"Liu C-G, Lin M-X, Xin Y, Sun M, Cui J, Liu D, et al. Metagenomics and non-targeted metabolomics reveal the role of gut microbiota and its metabolites in brain metastasis of non-small cell lung cancer. Thorac Cancer. 2025;16:e70068.","DOI":"10.1111\/1759-7714.70068"},{"key":"3609_CR59","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4103\/0974-2727.119872","volume":"5","author":"S Padhi","year":"2013","unstructured":"Padhi S, Dash M, Sahu R, Panda P. Urinary Tract Infection due to Paenibacillus alvei in a Chronic Kidney Disease: A Rare Case Report. J Lab Physicians. 2013;5:133\u20135.","journal-title":"J Lab Physicians"},{"key":"3609_CR60","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/INF.0000000000004668","volume":"44","author":"D Smith","year":"2025","unstructured":"Smith D, Bastug K, Burgoine K, Broach JR, Hammershaimb EA, Hehnly C, Morton SU, Osman M, Schiff SJ, Ericson JE. A Systematic Review of Human Paenibacillus Infections and Comparison of Adult and Pediatric Cases. Pediatr Infect Dis J. 2025;44:455\u201361.","journal-title":"Pediatr Infect Dis J"},{"key":"3609_CR61","doi-asserted-by":"crossref","unstructured":"Kelly SD, Butler J, Green H, Jones AM, Kenna DTD, Pai S, et al. Genomic insights and phenotypic characterization of three multidrug resistant Cupriavidus strains from the cystic fibrosis lung. J Appl Microbiol. 2025;136:lxaf093.","DOI":"10.1093\/jambio\/lxaf093"},{"key":"3609_CR62","doi-asserted-by":"crossref","unstructured":"Qin S, Xiao W, Zhou C, Pu Q, Deng X, Lan L, et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct Target Therapy. 2022;7:199.","DOI":"10.1038\/s41392-022-01056-1"},{"key":"3609_CR63","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","volume":"176","author":"C Jin","year":"2019","unstructured":"Jin C, Lagoudas GK, Zhao C, Bullman S, Bhutkar A, Hu B, et al. Commensal microbiota promote lung cancer development via \u03b3\u03b4 T cells. Cell. 2019;176:998\u20131013.e16.","journal-title":"Cell"},{"key":"3609_CR64","first-page":"3111","volume":"5","author":"X Yan","year":"2015","unstructured":"Yan X, Yang M, Liu J, Gao R, Hu J, Li J, Zhang L, Shi Y, Guo H, Cheng J, et al. Discovery and validation of potential bacterial biomarkers for lung cancer. Am J Cancer Res. 2015;5:3111\u201322.","journal-title":"Am J Cancer Res"},{"key":"3609_CR65","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1158\/2326-6066.CIR-18-0709","volume":"7","author":"X Yuan","year":"2019","unstructured":"Yuan X, Liu Y, Li G, Lan Z, Ma M, Li H, Kong J, Sun J, Hou G, Hou X, et al. Blockade of Immune-Checkpoint B7-H4 and Lysine Demethylase 5B in Esophageal Squamous Cell Carcinoma Confers Protective Immunity against P. gingivalis Infection. Cancer Immunol Res. 2019;7:1440\u201356.","journal-title":"Cancer Immunol Res"},{"key":"3609_CR66","doi-asserted-by":"crossref","unstructured":"Liu Y, Yuan X, Chen K, Zhou F, Yang H, Yang H, et al. Clinical significance and prognostic value of Porphyromonas gingivalis infection in lung cancer. Translational Oncol. 2021;14:100972.","DOI":"10.1016\/j.tranon.2020.100972"},{"key":"3609_CR67","doi-asserted-by":"crossref","unstructured":"Velo-Suarez L, Moalic Y, Guilloux C-A, Ame J, Lamoureux C, Gouriou S, et al. Genomic diversity in Porphyromonas: evidence of Porphyromonas catoniae commensality in lungs. Microb Genomics. 2025;11:001411.","DOI":"10.1099\/mgen.0.001411"},{"key":"3609_CR68","doi-asserted-by":"crossref","unstructured":"Keravec M, Mounier J, Guilloux C-A, Fangous M-S, Mondot S, Vallet S, et al. Porphyromonas, a potential predictive biomarker of Pseudomonas aeruginosa pulmonary infection in cystic fibrosis. BMJ Open Respiratory Res. 2019;6:e000374.","DOI":"10.1136\/bmjresp-2018-000374"},{"key":"3609_CR69","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/omi.12205","volume":"33","author":"CJ Beall","year":"2018","unstructured":"Beall CJ, Mokrzan EM, Griffen AL, Leys EJ. Cultivation of Peptidiphaga gingivicola from subgingival plaque: The first representative of a novel genus of Actinomycetaceae. Mol Oral Microbiol. 2018;33:105\u201310.","journal-title":"Mol Oral Microbiol"},{"key":"3609_CR70","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/jcpe.13330","volume":"47","author":"L Nibali","year":"2020","unstructured":"Nibali L, Sousa V, Davrandi M, Spratt D, Alyahya Q, Dopico J, Donos N. Differences in the periodontal microbiome of successfully treated and persistent aggressive periodontitis. J Clin Periodontol. 2020;47:980\u201390.","journal-title":"J Clin Periodontol"},{"key":"3609_CR71","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/jre.12922","volume":"56","author":"A Khocht","year":"2021","unstructured":"Khocht A, Orlich M, Paster B, Bellinger D, Lenoir L, Irani C, Fraser G. Cross-sectional comparisons of subgingival microbiome and gingival fluid inflammatory cytokines in periodontally healthy vegetarians versus non-vegetarians. J Periodontal Res. 2021;56:1079\u201390.","journal-title":"J Periodontal Res"},{"key":"3609_CR72","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/s41564-022-01196-8","volume":"7","author":"Z Yan","year":"2022","unstructured":"Yan Z, Chen B, Yang Y, Yi X, Wei M, Ecklu-Mensah G, Buschmann MM, Liu H, Gao J, Liang W, et al. Multi-omics analyses of airway host\u2013microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions. Nat Microbiol. 2022;7:1361\u201375.","journal-title":"Nat Microbiol"},{"key":"3609_CR73","doi-asserted-by":"crossref","unstructured":"Yu W, Wang K, He Y, Shang Y, Hu X, Deng X, et al. The potential role of lung microbiota and lauroylcarnitine in T-cell activation associated with checkpoint inhibitor pneumonitis. eBioMedicine. 2024;106:105267.","DOI":"10.1016\/j.ebiom.2024.105267"},{"key":"3609_CR74","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","volume":"18","author":"M Platten","year":"2019","unstructured":"Platten M, Nollen EAA, R\u00f6hrig UF, Fallarino F, Opitz CA. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discovery. 2019;18:379\u2013401.","journal-title":"Nat Rev Drug Discovery"},{"key":"3609_CR75","doi-asserted-by":"crossref","unstructured":"Wang G, Fan Y, Zhang G, Cai S, Ma Y, Yang L, et al. Microbiota-derived indoles alleviate intestinal inflammation and modulate microbiome by microbial cross-feeding. Microbiome. 2024;12:59.","DOI":"10.1186\/s40168-024-01750-y"},{"key":"3609_CR76","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/s41564-021-00970-4","volume":"6","author":"MF Laursen","year":"2021","unstructured":"Laursen MF, Sakanaka M, von Burg N, M\u00f6rbe U, Andersen D, Moll JM, Pekmez CT, Rivollier A, Michaelsen KF, M\u00f8lgaard C, et al. Bifidobacterium species associated with breastfeeding produce aromatic lactic acids in the infant gut. Nat Microbiol. 2021;6:1367\u201382.","journal-title":"Nat Microbiol"},{"key":"3609_CR77","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","volume":"55","author":"K Hezaveh","year":"2022","unstructured":"Hezaveh K, Shinde RS, Kl\u00f6tgen A, Halaby MJ, Lamorte S, Ciudad MT, et al. Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. Immunity. 2022;55:324\u201340.e8.","journal-title":"Immunity"},{"key":"3609_CR78","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1200\/JCO.2017.72.7735","volume":"35","author":"TM Brasky","year":"2017","unstructured":"Brasky TM, White E, Chen C-L. Long-Term, Supplemental, One-Carbon Metabolism\u2013Related Vitamin B Use in Relation to Lung Cancer Risk in the Vitamins and Lifestyle (VITAL) Cohort. J Clin Oncol. 2017;35:3440\u20138.","journal-title":"J Clin Oncol"},{"key":"3609_CR79","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/annonc\/mdz002","volume":"30","author":"H Zuo","year":"2019","unstructured":"Zuo H, Ueland PM, Midttun \u00d8, Tell GS, Fanidi A, Zheng W, Shu X, Xiang Y, Wu J, Prentice R, et al. Vitamin B6 catabolism and lung cancer risk: results from the Lung Cancer Cohort Consortium (LC3). Ann Oncol. 2019;30:478\u201385.","journal-title":"Ann Oncol"},{"key":"3609_CR80","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1002\/ijc.24168","volume":"124","author":"F Colombo","year":"2009","unstructured":"Colombo F, Falvella FS, De Cecco L, Tortoreto M, Pratesi G, Ciuffreda P, Ottria R, Santaniello E, Cicatiello L, Weisz A, Dragani TA. Pharmacogenomics and analogues of the antitumour agent N6-isopentenyladenosine. Int J Cancer. 2009;124:2179\u201385.","journal-title":"Int J Cancer"},{"key":"3609_CR81","doi-asserted-by":"crossref","unstructured":"Jinendiran S, Teng W, Dahms H-U, Liu W, Ponnusamy VK, Chiu CC-C, et al. Induction of mitochondria-mediated apoptosis and suppression of tumor growth in zebrafish xenograft model by cyclic dipeptides identified from Exiguobacterium acetylicum. Sci Rep. 2020;10:13721.","DOI":"10.1038\/s41598-020-70516-x"},{"key":"3609_CR82","doi-asserted-by":"crossref","unstructured":"Kaur S, Mendonca P, Soliman KFA. The anticancer effects and therapeutic potential of kaempferol in triple-negative breast cancer. Nutrients. 2024;16:2392.","DOI":"10.3390\/nu16152392"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03609-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03609-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03609-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:03:16Z","timestamp":1776081796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03609-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3609"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03609-2","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was conducted in accordance with the ethical principles of the Declaration of Helsinki and was approved by the Institutional Review Board of West China Hospital of Sichuan University (approval No. 2024[2611]). Written informed consent was obtained from all participants before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}